AstraZeneca announces global license agreement with Pinetree Therapeutics
PremiumThe FlyAstraZeneca announces global license agreement with Pinetree Therapeutics
3d ago
FDA Oncologic Drugs Advisory Committee Meeting
PremiumThe Fly
FDA Oncologic Drugs Advisory Committee Meeting
3d ago
Is AZN a Buy, Before Earnings?
PremiumPre-Earnings
Is AZN a Buy, Before Earnings?
4d ago
Is AstraZeneca Stock (NASDAQ:AZN) Overbought or Worth the Valuation?
PremiumMarket NewsIs AstraZeneca Stock (NASDAQ:AZN) Overbought or Worth the Valuation?
15d ago
AstraZeneca price target lowered to 13,100 GBp from 13,400 GBp at Guggenheim
PremiumThe Fly
AstraZeneca price target lowered to 13,100 GBp from 13,400 GBp at Guggenheim
16d ago
AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at Barclays
PremiumThe Fly
AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at Barclays
16d ago
AstraZeneca says Tagrisso with addition of chemo approved in China for NSCLC
PremiumThe FlyAstraZeneca says Tagrisso with addition of chemo approved in China for NSCLC
1M ago
UK Stocks: AstraZeneca’s (AZN) Imfinzi Disappoints in Advanced Lung Cancer Trial
PremiumGlobal Markets
UK Stocks: AstraZeneca’s (AZN) Imfinzi Disappoints in Advanced Lung Cancer Trial
1M ago
AstraZeneca’s Imfinzi demonstrated statistically significant improvement
PremiumThe Fly
AstraZeneca’s Imfinzi demonstrated statistically significant improvement
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100